Published in J Cell Physiol on April 01, 2002
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet (2006) 1.48
Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2). J Cell Commun Signal (2011) 0.79
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts. J Inflamm Res (2013) 0.78
Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction. Med Hypotheses (2013) 0.77
The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation. J Cell Mol Med (2015) 0.76
Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol (2006) 3.22
Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension (2010) 2.60
Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler Thromb Vasc Biol (2009) 1.67
Tryptase/Protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension (2011) 1.61
The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg (2006) 1.54
Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol (2002) 1.50
Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension (2009) 1.36
Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Card Fail (2005) 1.35
Membrane-associated matrix proteolysis and heart failure. Circ Res (2013) 1.35
Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol (2003) 1.32
Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload. Circulation (2002) 1.30
The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail (2002) 1.28
Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets (2009) 1.28
Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats. J Mol Cell Cardiol (2008) 1.27
Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes. PLoS One (2009) 1.24
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart. Hypertension (2010) 1.20
The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev (2004) 1.17
TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. Am J Physiol Heart Circ Physiol (2009) 1.17
Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res (2005) 1.16
Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail (2002) 1.10
Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol (2007) 1.10
Estrogen attenuates chronic volume overload induced structural and functional remodeling in male rat hearts. Am J Physiol Heart Circ Physiol (2009) 1.09
Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure. Am J Physiol Heart Circ Physiol (2007) 1.08
Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats. Am J Physiol Heart Circ Physiol (2008) 1.07
Endothelin-1 mediates cardiac mast cell degranulation, matrix metalloproteinase activation, and myocardial remodeling in rats. Am J Physiol Heart Circ Physiol (2004) 1.06
Cardiac mast cells: the centrepiece in adverse myocardial remodelling. Cardiovasc Res (2010) 1.06
Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem (2003) 1.03
Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy. Cardiovasc Res (2011) 1.02
Cardiac mast cell-mediated activation of gelatinase and alteration of ventricular diastolic function. Am J Physiol Heart Circ Physiol (2002) 1.02
Effects of collagen density on cardiac fibroblast behavior and gene expression. J Cell Physiol (2003) 1.01
Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circ Physiol (2007) 1.01
Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol (2004) 1.00
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype. Am J Physiol Heart Circ Physiol (2011) 0.96
Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. Am J Physiol Heart Circ Physiol (2005) 0.95
Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine (2010) 0.93
A gene expression classifier of node-positive colorectal cancer. Neoplasia (2009) 0.91
CYLD-mediated signaling and diseases. Curr Drug Targets (2015) 0.91
Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol (2010) 0.91
Temporal alterations in cardiac fibroblast function following induction of pressure overload. Cell Tissue Res (2010) 0.90
Blood-borne stem cells differentiate into vascular and cardiac lineages during normal development. Stem Cells Dev (2006) 0.90
Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats. J Appl Physiol (1985) (2005) 0.89
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells. Cardiovasc Res (2011) 0.88
Temporal evaluation of cardiac myocyte hypertrophy and hyperplasia in male rats secondary to chronic volume overload. Am J Pathol (2010) 0.88
Stem cell factor is responsible for the rapid response in mature mast cell density in the acutely stressed heart. J Mol Cell Cardiol (2012) 0.88
Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function. Microsc Microanal (2012) 0.88
Fractal and image analysis of morphological changes in the actin cytoskeleton of neonatal cardiac fibroblasts in response to mechanical stretch. Microsc Microanal (2007) 0.87
Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by chronic volume overload in rats. Clin Exp Pharmacol Physiol (2008) 0.86
Integrin shedding as a mechanism of cellular adaptation during cardiac growth. Am J Physiol Heart Circ Physiol (2003) 0.86
Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med (2013) 0.84
Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS One (2012) 0.84
Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts. Life Sci (2013) 0.84
Estrogenic modulation of inflammation-related genes in male rats following volume overload. Physiol Genomics (2012) 0.84
ETA selective receptor antagonism prevents ventricular remodeling in volume-overloaded rats. Am J Physiol Heart Circ Physiol (2009) 0.83
Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation. Mol Cell Biochem (2004) 0.82
IGF-1 modulation of rat cardiac fibroblast behavior and gene expression is age-dependent. Cell Commun Adhes (2003) 0.82
Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine (2012) 0.82
Regulation of matrix metalloproteinases is at the heart of myocardial remodeling. Am J Physiol Heart Circ Physiol (2008) 0.80
Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol Med (Maywood) (2014) 0.80
Temporal changes in integrin-mediated cardiomyocyte adhesion secondary to chronic cardiac volume overload in rats. Am J Physiol Heart Circ Physiol (2013) 0.79
Response of cardiac mast cells to atrial natriuretic peptide. Am J Physiol Heart Circ Physiol (2007) 0.79
Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways. J Biomech (2012) 0.79
Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2). J Cell Commun Signal (2011) 0.79
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts. J Inflamm Res (2013) 0.78
The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling. Methods Mol Biol (2015) 0.78
Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure. Regul Pept (2013) 0.77
Isolation of functional cardiac immune cells. J Vis Exp (2011) 0.77
Sparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slices. Cardiovasc Drugs Ther (2014) 0.76
Initial management of mass-casualty incidents due to firearms: improving survival. Bull Am Coll Surg (2013) 0.75
Quality assessment of graduate programs. J Vet Med Educ (2005) 0.75